Clinicopathological Significance of Transcription Factor p73 in Breast Cancers: Protein Expression and Transcriptomic Study.

Biomedicines · 2025 · PMC12561529 · PMID 41153767

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

borderline non-significantp = 0.056so close (0.05 < p ≤ 0.1)

In ER+ breast cancers, high p73 levels were borderline non-significant for shorter BCSS ( p = 0.056) ( Figure 1 J) and non-significant in ER- breast cancers ( p = 0.599) ( Figure 1 K). 3.2.

also in 434 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.